ATYR · aTYR PHARMA INC

$0.50 +0.01 (+2.13%) At close · Sep 3

Market Cap

$48.36M

98.09M

The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.

Type	Filing Date	Period
10-Q	2026-08-07	2026-06-30
8-K	2026-08-07	—
8-K	2026-07-31	2026-07-30
8-K	2026-06-08	2026-06-03
Investor Event Transcript	2026-06-04	2026-06-30
8-K	2026-06-01	—
Investor Event Transcript	2026-05-20	2026-06-30
10-Q	2026-05-15	2026-03-31
8-K	2026-05-15	—
8-K	2026-05-11	—
Investor Event Transcript	2026-05-11	2026-06-30
DEF 14A	2026-03-26	—
Investor Event Transcript	2026-03-11	2026-03-31
10-K	2026-03-05	2025-12-31
8-K	2026-03-05	—
8-K	2025-12-05	2025-12-04
8-K	2025-11-06	—
10-Q	2025-11-06	2025-09-30
Investor Event Transcript	2025-09-15	2025-09-30
8-K	2025-09-15	—
8-K/A	2025-08-08	2025-08-07
8-K	2025-08-07	—
10-Q	2025-08-07	2025-06-30
8-K	2025-05-07	—
10-Q	2025-05-07	2025-03-31
8-K	2025-05-06	2025-05-01
DEF 14A	2025-03-19	—
8-K	2025-03-13	—
10-K	2025-03-13	2024-12-31
8-K	2024-12-23	—
8-K	2024-12-12	2024-12-10
8-K	2024-11-07	—
10-Q	2024-11-07	2024-09-30
8-K	2024-08-13	—
10-Q	2024-08-13	2024-06-30
8-K	2024-07-22	—
8-K	2024-05-29	2024-05-22
8-K	2024-05-02	—
10-Q	2024-05-02	2024-03-31
DEF 14A	2024-04-05	2024-05-22
8-K	2024-03-14	—
10-K	2024-03-14	2023-12-31
10-Q	2023-11-09	2023-09-30
8-K	2023-11-09	—
8-K	2023-09-26	—
8-K	2023-09-11	2023-09-10
10-Q	2023-08-09	2023-06-30
8-K	2023-08-09	—
8-K	2023-05-19	2023-05-17
8-K	2023-05-09	—

Showing 1–50 of 110 filings

Key facts CIK 1339970 CUSIP 002120202 13F (30d) 77 filings 76 filers Visit website Investor relations